There was a major pandemic-induced pause in healthcare mergers & acquisitions activity in early 2020. However, the industry quickly recovered, extending the momentum from the second half of 2020, when a flurry of acquisitions was announced into 2021, driven by digital health and virtual care.

Between 2020 and 2021, deal volumes and values in the health industry climbed by 32 percent and 65 percent respectively. The health-tech space has seen a burst of deals in 2021 with IT giant Oracle’s massive $28.2 billion acquisition of Cerner operating in the Health information vertical. And we foresee innovative biotech and medical device companies will continue to be potential M&A targets.

To gain a deeper understanding of how the M&A landscape evolved during this time, we at Healthark Insights, have compiled and listed the top 10 Healthcare and Life science M&A Deals that shaped the M&A space this year.